Outlook Therapeutics, Inc. · NASDAQ:OTLK

Great Point Partners LLC reported a 6.37% stake in Outlook Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Great Point Partners LLC reported a 6.37% stake in Outlook Therapeutics, Inc., 2,220,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
6.37%
Shares
2,220,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Great Point Partners, LLC6.37%2,220,000
Dr. Jeffrey R. Jay, M.D.6.37%2,220,000
Ms. Lillian Nordahl6.37%2,220,000

Source

View original at SEC

Related